Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(PRX, CLNO, KMX, PWRM, LRY) Stock in Action by Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced a restructuring of its branded division, Strativa Pharmaceuticals, as part of a strategic assessment. As a result, there has been a workforce reduction of approximately 100. The Company believes this initiative will position Strativa to achieve profitability in the near term. Patrick G. LePore, Chairman, CEO and President of Par Pharmaceutical Companies, Inc., stated, "To achieve our goal of optimizing Strativa's potential, we found it necessary to reduce the number of sales representatives and focus on Megace ES and Nascobal at this time." Mr. LePore continued, "We remain fully committed to the branded business and believe it is a valuable platform for future growth."

Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit
www.parpharm.com.

*******************

http://pennyomega.com/img/clno.jpg Cleantech Transit Inc. (OTCPK:CLNO)

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (
www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide.

Cleantech Transit, Inc. (OTCPK:CLNO) is pleased to announce it has met its funding requirement to secure the Company's ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

Biomass energy is derived from various sources which help in generating sufficient energy for use. The various source of generating energy from biomass are wood, waste, alcohol, garbage, landfill gases. Wood is either taken from trees or from the waste of industrial processes. The waste material of industry like paper making is really helpful in providing pulping liquor. The conversion of Biomass into useful energy can produce heat and electricity moreover it can also be converted to bio fuels. There are three ways of converting waste and wood into useful biomass energy and bio fuels. These methods include thermal conversion, chemical conversion and biochemical conversion.

Please visit Cleantech Transit, Inc. website www.cleantechtransitinc.com.

**********************

CarMax, Inc. (NYSE:KMX) reported record results for the first quarter ended May 31, 2011. Net sales and operating revenues increased 18% to $2.68 billion from $2.26 billion in the first quarter of last year. Comparable store used unit sales increased 6% for the quarter. Total used unit sales rose 8% in the first quarter. Total wholesale unit sales increased 32% in the first quarter. Net earnings increased 25% to $126.3 million, or $0.55 per diluted share, compared with $101.1 million, or $0.44 per diluted share, earned in the first quarter of fiscal 2011. Net earnings were increased by approximately $0.03 per share in both the current year period and the prior period as a result of favorability in the CarMax Auto Finance (NYSE:CAF) provision for loan losses versus expectations.

CarMax, Inc., through its subsidiaries, operates as a retailer of used vehicles in the United States. It also sells vehicles that do not meet its retail standards to licensed dealers through on-site wholesale auctions, as well as sells new vehicles under franchise agreements.

**********************

power3 Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical
applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive, degenerative disease of the voluntary motor system. Over time the muscles that control functions such as movement, speech, swallowing, and breathing may become progressively weaker and eventually these muscles become paralyzed.

Please visit Power3 Medical Products, Inc website http://www.power3medical.com.

*******************

Liberty Property Trust (NYSE:LRY) announced that its board of trustees has declared a cash dividend of $0.475 per share on the company's common shares of beneficial interest for the second quarter of 2011. The dividend will be payable on July 15, 2011 to shareholders of record on July 1, 2011.

Liberty Property Trustis a leader in commercial real estate, serving customers in the United States and United Kingdom, through the development, acquisition, ownership and management of superior office and industrial properties.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (OTCPK:CLNO). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg